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Abstract 
The Type I cGMP-dependent protein kinase catalytic domain (residues 336671 from the Ia isoform) has been expressed as a cGMP independent 
kinase in a baculovirus ystem. Using peptide substrates, the protein retains similar substrate specificity as the native holoenzyme. The recombinant 
catalytic domain catalyzes the phosphorylation of histone, but does not display the inhibition using non-substrate histones which has been described 
for the holoenzyme. The catalytic domain is an active kinase in mammalian cells also since vascular smooth muscle cells transfected with the cDNA 
encoding the catalytic domain display altered morphology. The catalytic domain of G-kinase may be a useful tool for delineating the role of 
cGMP-mediated protein phosphorylation in cell systems. 
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1. Introduction 
Cyclic GMP-dependent protein kinase (G-kinase) me- 
diates many of the actions of cGMP in vascular smooth 
muscle, platelets, and neutrophils (for reviews, see [l-3]). 
The enzyme was first identified in arthropod tissues [4] 
and was subsequently purified from bovine lung [5,6]. 
There are two classes of G-kinase, a Type I which exists 
as a dimer of identical subunits, and a Type II which 
exists as a monomer. The Type I enzyme is expressed as 
two isoforms, an CI and a j? isoform which differ from 
each other only in the amino terminus where dimeriza- 
tion is believed to occur [7-91. The cDNAs encoding the 
Type Ia and I/? have been isolated from bovine [lo] and 
human sources [111, and the Type II from Drosophila [ 121 
and mouse [13]. The predicted sequences of the Type I 
enzyme from bovine and human tissues are nearly iden- 
tical, indicating a high degree of conservation. Further- 
more, the G-kinase cDNAs isolated from Drosophila are 
highly homologous with the mouse Type II enzyme as 
well as bovine and human Type I enzymes in regions 
consisting of cGMP binding and catalytic function. 
The domain structure of G-kinase indicates that the 
enzyme consists of a cGMP binding domain homologous 
with that of the regulatory subunit of CAMP-dependent 
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protein kinase (A-kinase), and a catalytic domain homol- 
ogous with that of the catalytic subunit of A-kinase as 
well as catalytic domains from other protein kinases. 
This suggests that the catalytic domain of G-kinase 
might be functional as a protein separated from the reg- 
ulatory domain. Although the cDNAs encoding G- 
kinase have been expressed in transfected cells [13,14], 
expression of an active enzyme in bacteria has not been 
successful. This has hampered further characterization 
of the enzyme, especially those designed to understand 
the catalytic mechanism of action. 
It has been know that proteolytic treatment of the 
enzyme results in a catalytically active kinase that still 
retains cGMP binding activity as well as other functional 
domains [ 15,161. No studies to date have addressed the 
existence of an isolated catalytic domain of G-kinase, 
however. In this report, we describe a PCR-mediated 
cloning procedure for the isolation of cDNAs encoding 
the cGMP-dependent protein kinase catalytic domain. 
This cDNA has been successfully expressed in the bacu- 
lovirus-Sl9 insect cell system. Some properties of the 
expressed protein are described. 
2. Materials and methods 
2.1. Construction of cDNAs for G-kinase la using PCR 
Fresh bovine lung mRNA was isolated using a modified guanidinium 
isothiocyante method [17], and purified on oligodT cellulose. The 
mRNA was converted to first strand cDNA using Abelson Maloney 
virus reverse transcriptase, and the cDNA was used as the template for 
the construction of individual segments using PCR. For constructing 
the catalytic domain of G-kinase Ia, (bp 999-2016), sense oligonucleo- 
tides (CCC CTC GAG TTA AGC ATA TGA AGA TGC AGA AGC 
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TAA GGC) and antisense oligonucleotides (CCC CTC GAG TAA 
GAA GTC TAT GTC CCA TCC TGA GTT GTC) were used, where 
the underlined sequences represent XhoI restriction sites for sub- 
cloning. PCR was performed using 10 ng of cDNA constructed from 
3 pg mRNA, or in some cases 10 ng of lamda gt 11 DNA from a bovine 
lung cDNA library. TenpM of each of the primer oligonucleotides were 
used to amplify the various cDNAs from template. Forty cycles of 
thermal denaturation and renaturation were performed with steps at 
the following temperatures and times: 94°C for 1 min, 55°C for 2 min, 
and 72°C for 2 min. An initial 94°C denaturation step for 3 min prior 
to thermal cycling was included. The amplified fragments were isolated 
on 1% agarose gels and sub-cloned into the XhoI restriction sites in 
pSK+ and sequenced using the dideoxynucleotide chain termination 
method [ 181. 
2.2. Ligation of the cDNA encoding the G-kinase catalytic domain 
The fragment consisting of the entire coding region for the catalytic 
domain was ligated in pSK+ at the XhoI site. Confirmation of the 
orientation was obtained by restriction enzyme analysis and eventually 
by sequencing the cDNA encoding G-kinase. The aim of the PCR 
strategy was to design specific cDNA sequences encoding the individual 
domains of G-kinase, especially that encoding the catalytic domain. 
Thus, we prepared the catalytic domain for expression using linkers 
encoding the translational initiation codon. The vector was digested 
with NdeI and the overhanging ends were blunt-ended using Klenow 
polymerase. Linkers containing the NcoI restriction site having the 
ATG in frame with the remaining coding sequence was ligated to the 
blunt NdeI site. The IO-mer linker, AGC CAT GGC T, was ligated to 
the blunt NdeI-cleaved fragment o yield the following coding sequence 
for the catalytic domain: 
. . . AGCCATGGCT TAT GAA .,. 
M A Y-336 E 
where the underlined sequence indicates the correct reading frame for 
the catalytic domain. 
2.3. Expression of the catalytic domain of G-kinase in insect cells 
The coding sequence for G-kinase catalytic domain was removed 
from pSK+ using XhoI digestion and cloned into the NheI site in 
BlueBaQ (pBB) transfer vector after blunt-ending with the Klenow 
polymerase to create pBB/GK. The recombinant vector was grown in 
E. coli and purified by Magic Maxi prep @omega). Sf9 cells were 
co-transfected with 10 pg of pBB/GK and 1 pg linear wild type bacu- 
lovirus DNA, AcMNPV (Invitrogen), using liposome-mediated trans- 
fection. Cells were grown for 5 days in Grace’s medium supplemented 
with 10% fetal bovine serum (FBS), after which the medium containing 
virus particles was harvested. Recombinant virus was isolated from 
wild-type virus by plaque purification using /I-galactosidase as a 
marker. After six rounds of plaque purification, the recombinant virus 
was judged near homogeneous since a 106-fold ilution of virus yielded 
only blue colonies of St9 cells in soft-agar plates, and the plaques were 
occlusion body-negative. The protein kinase inhibitor, H-8 (50,~M) was 
added to Grace’s medium in order to prevent detachment of cells during 
expression of the active catalytic domain. 
For expression of G-kinase catalytic domain, Sf9 cells were grown 
in 60 mm’ tissue culture plates and infected with 10 pfu/cell or MO1 = 
10. After 1 h, the medium was changed and cells were grown for up to 
5 days at 27°C. Cells were harvested at various points and assessment 
of expression was determined by Western blot analysis and activity 
assays. 
2.4. Expression of the catalytic domain in cultured vascular smooth 
muscle cells 
The coding sequence for the catalytic domain was removed from 
pSK+ using XhoI digestion and cloned in to the XhoI site of pMEP4 
eukaryotic expression vector to create pMEP/GK. The recombinant 
vector was grown in E. coli and purified. Passage 3 rat aortic smooth 
muscle cells (RASMC) deficient in endogenous G-kinase were trans- 
fected with 5 pg of pMEP/GK or 5 pg pMEP4 as a control using 10 
pg of Transfectam reagent for 15 min at room temperature to precipi- 
tate the DNA/liposome complex. The precipitate was added to the cell 
monolayer and incubated for 6 h at 37°C and 10% CO,. The transfec- 
tion was terminated by adding DMEM with 20% FBS. Stably-trans- 
fected cells were selected using 40 &ml hygromycin b, and the estab- 
lished cell lines were maintained in culture in 25 &ml hygromycin b. 
For expression of the catalytic domain, the transfected RASMC were 
plated at 30% confluence in 100 mm* tissue culture plates and were 
allowed to attach overnight at 37°C and 10% CO’. The cells were then 
serum deprived for 48 h in DMEM and 1 mg/ml bovine serum albumin 
followed by induction by the addition of DMEM plus 10% FBS with 
100 PM ZnSO,. 
2.5. Assay for G-kinase and catalytic domain activity 
Cells (approximately 1x 10’) were harvested by rinsing the monolay- 
ers twice with phosphate-buffered saline, followed by the addition of 
0.5 ml of 20 mM potassium phosphate, pH 6.8, 2 mM EDTA, 15 mM 
/I-mercaptoethanol (PEM buffer). The cells were scraped from the 
plates and sonicated, and the particulate fraction removed by centrifu- 
gation at 10,000 x g for 10 min. Ten ~1 of the extract was assayed for 
G-kinase in 100 ,ul of assay buffer consisting of 50 mM Tris-HCl, 
pH 7.5, 20 mM magnesium acetate, 0.2 mM [Y-~*P]ATP (200 cpm/ 
pmol), and either histone F2b (0.1 mg/ml) or 100 PM of peptide sub- 
strate selective for G-kinase, RKISASEFDRPL, initially described by 
Colbran et al. [19]. All assays for G-kinase were performed in the 
presence of 0.9pM protein kinase inhibitor peptide (5-24). Assays were 
conducted at 30°C for 5 min and terminated by aliquoting histone or 
the peptide to Whatman 3MM filter paper or P81 phosphocellulose 
paper, respectively. A-kinase activity was determined using either his- 
tone or kemptide as the substrate using the same assay conditions. 
2.6. Materials 
The bovine lung cDNA library from which the catalytic domain was 
cloned was purchased from Clontech Laboratories, Inc. (Palo Alto, 
CA). Restriction endonucleases were from BRL (Gaithersburg, MD) 
or Stratagene (La Jolla, CA). Deoxyribonucleotides were purchased 
from Pharmacia, Inc. (Piscataway, NJ). Reagents for baculovirus ex- 
pression, transfer vectors, and wild type virus and Abelson Maloney 
Virus reverse transcriptase were obtained from Invitrogen (LaJolla, 
CA). Transfectam Reagent was purchased from Promega, Inc (Madi- 
son. WI). Radioactive ATP was from New Endand Nuclear (Wilmina- 
ton; DE). Peptides were synthesized and purchased from‘Resear;h 
Genetics, Inc. (Huntsville, AL). Histone Type VIII-S was from Sigma, 
Co. (St. Louis, MO) while F2b was from Worthington (Freehold, NJ). 
3. Results 
3.1. Cloning and expression of the G-kinase catalytic 
domain 
The sequence homology between the catalytic subunit 
of the A-kinase and the G-kinase Type Iol catalytic do- 
main is shown below: 
C-subunit: 
. . EFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFG... 
G-kinase: 
MAYEDAEAKAKYEAEAAFFANLKLSDFNIIDTLGVGGFG... 
The glycine loop is underlined for residues SO-55 in the 
catalytic subunit and residues 34-39 of the catalytic do- 
main. Little homology is observed between the two pro- 
teins before the glycine loop. It will also be noted that the 
G-kinase catalytic domain is truncated by 16 residues 
relative to the catalytic subunit of A-kinase. 
Expression of immunoreactive G-kinase catalytic do- 
main in St9 insect cells following infection with bacu- 
lovirus is shown in Fig. 1. Polyclonal antibodies to the 
holoenzyme recognized a band of 38 kDa which was 
maximally expressed at 48 and 72 h post-infection 
(Fig. 1A). This corresponded to the predicted size of the 
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A IB, cells infected with recombinant virus demonstrated 
a lo-fold increase in peptide phosphorylation relative to 
cells infected with wild-type virus. Very little kinase ac- 
tivity was present in the wild-type virus extracts either in 
the presence or absence of 2 ,uM cGMP. These results 
demonstrate that the catalytic domain is fully active in 
Sf9 cells and is independent of cGMP for activity. 
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Fig. 1. (A) Immunoreactivity of G-kinase catalytic domain in extracts 
of St9 cells. St9 cells were grown as monolayers in T-75 flasks in Grace’s 
medium supplemented with 10% FBS, and harvested at the times indi- 
cated. Cells were scraped from the plates, centrifuged, and homoge- 
nized. Extract proteins were then resolved by 10% SDS-PAGE. After 
transfer to nitrocellulose, the blots were probed with rabbit anti-bovine 
G-kinase. (B) G-kinase activity in Sfp cell extracts. Extracts were pre- 
pared as described in section 2. G-kinase activity was assayed in the 
absence of cGMP and in the presence of the protein kinase inhibitor 
peptide 5-24 using 100 PM BPDEtide as the substrate. 
catalytic domain. For comparison, 10 ng of purified G- 
kinase holoenzyme, M, = 79 kDa, is shown (GK). Ex- 
tracts from wild-type (WT) virus-infected cells displayed 
no immunoreactive G-kinase at 79 kDa or catalytic do- 
main. Activity of the catalytic domain was assessed using 
a selective G-kinase substrate, the BPDEtide [19], as- 
sayed in the absence of cGMP and the presence of the 
protein kinase inhibitor peptide 5-24. As shown in Fig 
3.2. Substrate spec@ity of the catalytic domain 
Previous studies from several aboratories have shown 
that while G-kinase demonstrates overlapping substrate 
specificity with several other protein kinases, especially 
the A-kinase, there appear to be specificity determinants 
for the G-kinase as well [20,21]. Nevertheless, the molec- 
ular basis for specificity is not well-defined and may 
relate to the recognition of specific sequence motifs in 
substrates by the catalytic domain, by the targeting of the 
holoenzyme to subcellular structures containing sub- 
strates for protein kinases, or both. Thus, we examined 
the phosphorylation of different peptide substrates for 
the G-kinase catalytic domain and holoenzyme. As 
shown in Table 1, G-kinase and the G-kinase catalytic 
domain phosphorylated the BPDEtide substrate slightly 
better than the Kemptide substrate which was preferen- 
tially phosphorylated by the catalytic subunit of A- 
kinase. In fact, the catalytic subunit of A-kinase cata- 
lyzed the phosphorylation of the BPDEtide only 3% as 
well as kemptide; both G-kinase preparations however 
catalyzed the phosphorylation of the BPDEtide more 
than 5 times the rate of that by the A-kinase catalytic 
subunit, thus confirming previous observations by 
Table 1 
Peptide phosphorylation by G-kinase, the G-kinase catalytic domain, 
and the catalytic subunit of CAMP-dependent protein kinase 
Substrate Kinase Percent maximum 
phosphorylation 
LRRASLG (kemptide) G-kinase 16.2 
Catalytic domain 15.0 
C-subunit 100.0 
RKISASEFDRPL 
(BPDE-tide) 
G-kinase 17.6 
Catalytic domain 14.4 
C-subunit 3.2 
GRRESLTSFG (IP,Rtide) G-kinase 100.0 
Catalytic domain 100.0 
C-subunit 83.4 
Percent maximal phosphorylation is the pmoles/min/mg protein of each 
peptide divided by the best peptide substrate for each kinase. Peptides 
were used at 100pM. The G-kinase (10 nM) was the ICY isoform purified 
to homogeneity from bovine lung; the C-subunit (20 nM) was purified 
to homogeneity from bovine heart; the Catalytic domain of G-kinase 
was partially puritied from Sf9 cell extracts by Econo Q chromatogra- 
phy. The specific activity of the G-kinase was 2.4 pmol/min/mg using 
the IP,Rtide, of the C-subunit was 4.3 ~mol/min/mg using the kemp- 
tide, and of the catalytic domain 86.6 nmol/min/mg using the 
IP,Rtide. 
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G-kinase can be attributed to interaction(s) of polyca- 
tionic proteins at sites distinct from the catalytic domain. 
In this sense, the catalytic domain may function more 
like the A-kinase catalytic subunit in catalyzing the phos- 
phorylation of protein substrates. 
3.4. Other properties 
_ . 
Histonr FZb Hislone F2b + lug-r,cn “Islone 
AlOlll3 Arg-rich Histone Alone 
The G-kinase catalytic domain was insensitive to the 
effects of the A-kinase protein kinase inhibitor peptide 
as all assays were performed in the presence of the pep- 
tide. On the other hand, KT5823 a reportedly selective 
inhibitor of G-kinase, inhibits the holoenzyme and the 
catalytic domain with equal potency (< 1 ,uM) (data not 
shown). The catalytic domain has been partially purified 
by elution from Econo Q columns with 400-500 mM 
NaCl at pH 8.0, suggesting a strongly anionic protein 
(Fig. 3). The dilute enzyme is rather unstable, and in its 
purified form the half-life was approximately 2.5 h at 
4°C similar to the A-kinase C subunit. 
Fig. 2. Effects of arginine-rich histone (histone VIII-S) on F2b histone 
phosphorylation by the holoenzyme of G-kinase (10 nM), the catalytic 
domain of Cl-kinase, and the catalytic subunit of A-kinase (20 nM). 
Proteins were diluted buffer containing 1 mg/ml bovine serum albumin 
to yield similar specific activities before assay. Histone concentrations 
were 0.5 mg/ml in each instance. 
Colbran, et al [19]. Our laboratory has observed that the 
purified inositol 1,4,5-trisphosphate (IP,) receptor is an 
excellent substrate for G-kinase in vitro. As shown in 
Table 1, all three kinase preparations phosphorylated the 
IP, receptor peptide substrate with similar potency. Col- 
lectively, these results demonstrate that the catalytic do- 
main of G-kinase and the holoenzyme recognize similar 
substrates in vitro and indicate that the G-kinase does 
indeed recognize specific substrates at the peptide bind- 
ing domain. 
3.3. Phosphorylation of histones by the G-kinase catalytic 
domain 
It has been known for a number of years that G-kinase 
interacts with histone substrates and other polycationic 
proteins at undetermined sites [22,23]. This interaction 
results in a decrease in the activity of the enzyme and has 
hampered assays and characterization of the enzyme 
from tissue extracts. In order to aid in the identification 
of the putative interaction site(s) on G-kinase for polyca- 
tionic proteins, we compared the phosphorylation of his- 
tone F2b (a good histone substrate for G-kinase) by the 
holoenzyme and the catalytic domain in the presence and 
absence of arginine-rich histone (a poor substrates for 
G-kinase and an inhibitory polycationic protein). As 
shown in Fig. 2, arginine-rich histone inhibited the ca- 
pacity of the holoenzyme to phosphorylate F2b histone 
by approximately 80%; such inhibition was not observed 
for the catalytic domain of G-kinase. For comparison, 
the effects of arginine-rich histone on the capacity of the 
catalytic subunit of A-kinase to phosphorylate F2b is 
also shown. Thus, the inhibition of the holoenzyme of 
3.5. Effects of the G-kinase catalytic domain on cell 
morphology 
Cultured RASMC stably transfected with the cDNA 
encoding the catalytic domain of G-kinase demonstrated 
conspicuous morphological changes. Specifically, the 
cells were transformed from a phenotype characterized 
by flattened phase-lucent morphology (Fig. 4A) to cells 
that were characterized by an elongated, ‘hill and valley’ 
structure (Fig. 4B). Cells transfected with the catalytic 
domain also tend to grow in parallel arrays rather than 
randomly. These phenotypic alterations resemble super- 
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Fig. 3. Econo Q chromatography of the G-kinase catalytic domain 
expressed in St9 cells. Approximately 3 x lo6 cells/ml were harvested 
from a 500 ml spinner culture and homogenized in 1 ml of PEM buffer 
using a ultraturax homogenizer. The homogenate was centrifuged at 
10,000 x g for 10 min, and the extract was applied to a 1 ml Econo Q 
column equilibrated with PEM buffer. The column was eluted with a 
75 ml NaCl gradient (0 to 600 mM) in PEM buffer using a Bio-Rad 
Econosystem pump. Fractions were collected and assayed for G-kinase 
as described in section 2. 
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Fig. 4. Morphological properties of RASMC expressing the G-kinase 
catalytic domain. Cells in passage 3 and deficient in endogenous 
G-kinase were transfected with pMEP4 vector alone (panel A) or 
pMEP/GK (panel B) as described in section 2. After serum-deprivation 
for 48 hrs, expression was induced using DMEM plus 10% FBS con- 
taining 100 PM &SO,. Cell monolayers were photographed using a 
phase- contrast Nikon microscope quipped with a camera. Magnifica- 
tion x 800. 
ficially at least the differentiated, contractile phenotype 
associated with primary isolates of VSMC. These results 
indicate that the catalytic domain of G-kinase can fi.mc- 
tion as an active catalytic moiety in mammalian cultured 
cells. 
4. Discussion 
The catalytic domain of G-kinase has been success- 
fully expressed in a baculovirus system. The enzyme is 
independent of cGMP for activity and displays many 
properties similar to that of the holoenzyme with respect 
to substrate recognition and phosphorylation. These re- 
sults confirm the notion that the catalytic domain of the 
G-kinase may be independently folded from the regula- 
tory portion of the molecule during synthesis to produce 
an active catalytic core. The enzyme has been purified 
approximately lo-fold by mono Q ion-exchange chroma- 
tography from Sl9 cell extracts, and appears to be 10% 
pure at this point. This indicates that the catalytic do- 
main comprises 1% to 0.1% of St9 soluble protein. It was 
observed during expression of the active catalytic do- 
main that cells became detached from the culture dishes, 
but were still viable as judged by trypan blue exclusion. 
The mechanism for this effect was not clear, but subse- 
quent plaque purification of recombinant virus was ham- 
pered unless the kinase activity was blocked. To do this, 
we employed H-8, a cyclic nucleotide kinase inhibitor, to 
allow purification of recombinant virus particles. A sim- 
ilar situation may be encountered by other investigators 
attempting to express active kinases in the baculovirus 
system. 
For many years, it has been noticed that assay meth- 
ods using histones as substrates for G-kinase has yielded 
contradictory results. It is now known that G-kinase 
activity is suppressed when using high concentrations of 
histone as the substrate. It had been speculated that his- 
tones bind to sites distinct from the catalytic site and 
inhibit activity [23]. The results reported here demon- 
strate for the first time that this indeed is the case since 
the holoenzyme, but not catalytic domain, is inhibited by 
non-substrate polycationic histones. 
An interesting effect on RASMC morphology was ob- 
served in cells expressing the G-kinase catalytic domain. 
The cells expressing the catalytic domain changed to a 
fusiform, elongated morphology similar to that dis- 
played by primary isolates of RASMC or differentiated 
SMC found in the medial layer of arteries. Control trans- 
fectants, on the other hand, retained the dedifferentiated 
morphology observed for many types of SMC grown 
and passaged in vitro. It is tempting to speculate that 
cGMP-dependent protein phosphorylation might be in- 
volved in the phenotypic and growth properties of 
RASMC. More studies, however, are needed to deter- 
mine the mechanisms underlying the phenotypic modu- 
lation observed in cells expressing G-kinase. 
Recently the holoenzyme of G-kinase Ia has been ex- 
pressed at high levels in baculovirus [24]. this provides 
an alternate method to the standard lung purification for 
obtaining G-kinase. On the other hand, the expression 
of an active catalytic domain of G-kinase may prove 
useful in delineating the role of cGMP in cellular sys- 
tems. Because cGMP can interact with multiple receptor 
proteins to effect cell function [3], the availability of the 
cGMP-independent G-kinase may help define the roles 
of specific cGMP-dependent protein phosphorylation in 
cells. Furthermore, pathways leading to cGMP forma- 
tion, e.g. nitric oxide (NO), can be by-passed in cells 
expressing the catalytic domain of G-kinase thus elimi- 
nating other potential effects of NO. 
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